Efficacy of <i>Helicobacter pylori</i> eradication therapy of infection with omeprazole and rabeprazole in overweight and obese patients-Reference-Cited by-同舟云学术

Efficacy of Helicobacter pylori eradication therapy of infection with omeprazole and rabeprazole in overweight and obese patients

Published:2020-05-22 Issue:4 Volume: Page:100-105
ISSN:2658-5790
Container-title:Meditsinskiy sovet = Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Dicheva D. T.¹^ORCID,Karaulov S. A.¹^ORCID,Andreev D. N.¹^ORCID,Berezutskaya O. E.²,Golovkina N. L.²

Affiliation:

1. Moscow State University of Medicine and Dentistry named after A.I. Yevdokimov

2. Main Clinical Hospital of the Ministry of Internal Affairs of the Russian Federation

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Mayev I.V., Andreyev D.N. Helicobacter pylori infection and associated diseases. Moscow: Remedium; 2018. (In Russ.) Available at: https://remedium.ru/public/books/infektsiya-helicobacter-pylori-i-assotsiirovannye-zabolevaniya.

2. Crowe S.E. Helicobacter pylori Infection. N Engl J Med. 2019;380(12):1158-1165. doi: 10.1056/NEJMcp1710945.

3. Flores-Trevino S., Mendoza-Olazaran S., Bocanegra-Ibarias P., Maldonado-Garza H.J., Garza-Gonzalez E. Helicobacter pylori drug resistance: therapy changes and challenges. Expert Rev Gastroenterol Hepatol. 2018;12(8):819-827. doi: 10.1080/17474124.2018.1496017.

4. Maev I.V., Andreev D.N. Molecular-genetic predictors of resistance to antiHelicobacter pylory therapy. Terapevticheskiy arkhiv = Therapeutic Archive. 2017;89(8):5-12. (In Russ.) doi: 10.17116/terarkh20178985-12.

5. Uotani T., Miftahussurur M., Yamaoka Y. Effect of bacterial and host factors on Helicobacter pylori eradication therapy. Expert Opin Ther Targets. 2015;19(12):1637-1650. doi: 10.1517/14728222.2015.1073261.